vs
STANDARD BIOTOOLS INC.（LAB）与LIGHTPATH TECHNOLOGIES INC（LPTH）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是LIGHTPATH TECHNOLOGIES INC的1.2倍（$19.6M vs $16.4M），LIGHTPATH TECHNOLOGIES INC净利率更高（-57.5% vs -177.4%，领先119.9%），LIGHTPATH TECHNOLOGIES INC同比增速更快（120.2% vs -11.5%），LIGHTPATH TECHNOLOGIES INC自由现金流更多（$2.0M vs $-23.1M），过去两年LIGHTPATH TECHNOLOGIES INC的营收复合增速更高（45.7% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
LightPath Technologies Inc是一家精密光学组件及组件生产商，主营非球面透镜、红外光学器件、光纤产品等，服务工业自动化、航空航天、国防、医疗成像、电信等领域的全球客户，提供标准及定制化光学解决方案。
LAB vs LPTH — 直观对比
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $16.4M |
| 净利润 | $-34.7M | $-9.4M |
| 毛利率 | 48.5% | 36.8% |
| 营业利润率 | -168.5% | -52.6% |
| 净利率 | -177.4% | -57.5% |
| 营收同比 | -11.5% | 120.2% |
| 净利润同比 | -28.8% | -260.1% |
| 每股收益（稀释后） | $-0.09 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $16.4M | ||
| Q3 25 | $19.6M | $15.1M | ||
| Q2 25 | $21.8M | $12.2M | ||
| Q1 25 | $40.8M | $9.2M | ||
| Q4 24 | — | $7.4M | ||
| Q3 24 | $22.1M | $8.4M | ||
| Q2 24 | $22.5M | $8.6M | ||
| Q1 24 | $45.5M | $7.7M |
| Q4 25 | — | $-9.4M | ||
| Q3 25 | $-34.7M | $-2.9M | ||
| Q2 25 | $-33.5M | $-7.1M | ||
| Q1 25 | $-26.0M | $-3.6M | ||
| Q4 24 | — | $-2.6M | ||
| Q3 24 | $-26.9M | $-1.6M | ||
| Q2 24 | $-45.7M | $-2.4M | ||
| Q1 24 | $-32.2M | $-2.6M |
| Q4 25 | — | 36.8% | ||
| Q3 25 | 48.5% | 29.8% | ||
| Q2 25 | 48.8% | 22.0% | ||
| Q1 25 | 48.4% | 29.1% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | 54.9% | 33.9% | ||
| Q2 24 | 46.1% | 29.2% | ||
| Q1 24 | 53.1% | 20.9% |
| Q4 25 | — | -52.6% | ||
| Q3 25 | -168.5% | -16.6% | ||
| Q2 25 | -118.1% | -38.0% | ||
| Q1 25 | -80.8% | -36.3% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | -120.9% | -16.4% | ||
| Q2 24 | -134.5% | -25.6% | ||
| Q1 24 | -132.2% | -33.6% |
| Q4 25 | — | -57.5% | ||
| Q3 25 | -177.4% | -19.2% | ||
| Q2 25 | -153.7% | -57.8% | ||
| Q1 25 | -63.8% | -39.1% | ||
| Q4 24 | — | -35.2% | ||
| Q3 24 | -122.0% | -19.3% | ||
| Q2 24 | -203.3% | -27.3% | ||
| Q1 24 | -70.6% | -33.7% |
| Q4 25 | — | $-0.20 | ||
| Q3 25 | $-0.09 | $-0.07 | ||
| Q2 25 | $-0.09 | $0.19 | ||
| Q1 25 | $-0.07 | $-0.44 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | $-0.07 | $-0.04 | ||
| Q2 24 | $-0.12 | $-0.15 | ||
| Q1 24 | $-0.27 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $73.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $77.9M |
| 总资产 | $539.6M | $148.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $73.6M | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | $4.9M | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | $535.0K | ||
| Q1 24 | $55.0M | $599.4K |
| Q4 25 | — | $77.9M | ||
| Q3 25 | $399.7M | $21.4M | ||
| Q2 25 | $424.5M | $15.6M | ||
| Q1 25 | $454.6M | $15.7M | ||
| Q4 24 | — | $26.7M | ||
| Q3 24 | $489.3M | $29.4M | ||
| Q2 24 | $510.3M | $30.2M | ||
| Q1 24 | $577.3M | $31.7M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | $539.6M | $87.3M | ||
| Q2 25 | $557.0M | $81.5M | ||
| Q1 25 | $579.6M | $81.4M | ||
| Q4 24 | — | $45.8M | ||
| Q3 24 | $681.5M | $48.4M | ||
| Q2 24 | $708.7M | $48.1M | ||
| Q1 24 | $777.7M | $49.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | 0.02× | ||
| Q1 24 | 0.10× | 0.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $2.8M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $2.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 12.0% |
| 资本支出强度资本支出/营收 | 4.5% | 5.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-6.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $2.8M | ||
| Q3 25 | $-22.2M | $-1.1M | ||
| Q2 25 | $-20.7M | $-2.6M | ||
| Q1 25 | $-30.3M | $-3.2M | ||
| Q4 24 | — | $-737.4K | ||
| Q3 24 | $-27.9M | $-1.7M | ||
| Q2 24 | $-39.0M | $64.7K | ||
| Q1 24 | $-62.5M | $-394.2K |
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-23.1M | $-1.2M | ||
| Q2 25 | $-22.6M | $-3.3M | ||
| Q1 25 | $-35.3M | $-3.7M | ||
| Q4 24 | — | $-817.8K | ||
| Q3 24 | $-30.1M | $-1.8M | ||
| Q2 24 | $-41.0M | $-225.5K | ||
| Q1 24 | $-63.3M | $-802.5K |
| Q4 25 | — | 12.0% | ||
| Q3 25 | -118.1% | -8.1% | ||
| Q2 25 | -103.6% | -27.3% | ||
| Q1 25 | -86.6% | -40.0% | ||
| Q4 24 | — | -11.0% | ||
| Q3 24 | -136.4% | -21.2% | ||
| Q2 24 | -182.2% | -2.6% | ||
| Q1 24 | -138.9% | -10.4% |
| Q4 25 | — | 5.3% | ||
| Q3 25 | 4.5% | 0.5% | ||
| Q2 25 | 8.7% | 5.6% | ||
| Q1 25 | 12.4% | 4.6% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | 10.2% | 0.9% | ||
| Q2 24 | 8.6% | 3.4% | ||
| Q1 24 | 1.7% | 5.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LPTH
| Other | $7.9M | 48% |
| Infrared Components | $5.0M | 31% |
| Visible Components | $3.4M | 21% |
